Selection process begins for new research approach
The funds, which amount to $75 million, will be used to reduce the worldwide burden of coronary heart disease. There are hundreds of applicants from around the world for the research fund.
The Joint Leadership Group represents the organizations that have provided the funds for the program. The organizations include Verily (previously Google Life Sciences), the American Heart Association (AHA), and AstraZeneca. The funds are part of the group’s novel new methods for developing scientific discoveries.
As of today, the Joint Leadership Group has chosen 26 different applicants who will continue through the next stage of the review process. The next step is to conduct in-person interviews with the applicants, finding which ones will make it to the final selection later this summer.
“We are very pleased with the wealth of scientific ideas, the diversity and synergies of the applicants and the concepts we received from hundreds of submissions representing 22 different countries,” Nancy Brown, CEO of the American Heart Association and a Joint Leadership Group member, said. “This is an incredible time for research. Together, we are unleashing the true power of science and innovation.”
Organizations in this story
American Heart Association 7272 Greenville Avenue Dallas, TX 75231